Quantitative Assessment of Serum Amino Acids and Association with Early-Onset Coronary Artery Disease

References

• Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–212. doi:10.1038/s41569-018-0119-430467329
   PubMed Web of Science ®Google Scholar
• Filippi E, Sentinelli F, Romeo S, et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age <or=50 years). J Mol Med. 2005;83(9):711–719. doi:10.1007/s00109-005-0667-z15877215
   PubMed Web of Science ®Google Scholar
• Ichihara S, Yamamoto K, Asano H, et al. Identification of a glutamic acid repeat polymorphism of ALMS1 as a novel genetic risk marker for early-onset myocardial infarction by genome-wide linkage analysis. Circ Cardiovasc Genet. 2013;6(6):569–578. doi:10.1161/CIRCGENETICS.111.00002724122612
   PubMedGoogle Scholar
• Mirzaei H, Suarez JA, Longo VD. Protein and amino acid restriction, aging and disease: from yeast to humans. Trends Endocrinol Metab. 2014;25(11):558–566. doi:10.1016/j.tem.2014.07.00225153840
   PubMed Web of Science ®Google Scholar
• Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics. 2006;6(17):4716–4723. doi:10.1002/pmic.20060010616888765
   PubMed Web of Science ®Google Scholar
• Guasch-Ferré M, Hruby A, Toledo E, et al. Metabolomics in Prediabetes and Diabetes: a Systematic Review and Meta-analysis. Diabetes Care. 2016;39(5):833–846. doi:10.2337/dc15-225127208380
   PubMed Web of Science ®Google Scholar
• Kühn T, Floegel A, Sookthai D, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016;14(1):13. doi:10.1186/s12916-016-0552-326817443
   PubMed Web of Science ®Google Scholar
• Hocher B, Adamski J. Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol. 2017;13(5):269–284. doi:10.1038/nrneph.2017.3028262773
   PubMed Web of Science ®Google Scholar
• Ibáñez C, Simó C, Martín-álvarez PJ, et al. Toward a predictive model of Alzheimer’s disease progression using capillary electrophoresis-mass spectrometry metabolomics. Anal Chem. 2012;84(20):8532–8540. doi:10.1021/ac301243k22967182
   PubMed Web of Science ®Google Scholar
• Shah SH, Bain JR, Muehlbauer MJ, et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet. 2010;3(2):207–214. doi:10.1161/CIRCGENETICS.109.85281420173117
   PubMedGoogle Scholar
• Dagogo-Jack S. Metabolomic prediction of diabetes and cardiovascular risk. Med Princ Pract. 2012;21(5):401–403. doi:10.1159/00033920322710603
   PubMed Web of Science ®Google Scholar
• Wurtz P, Havulinna AS, Soininen P, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774–785. doi:10.1161/CIRCULATIONAHA.114.01311625573147
   PubMed Web of Science ®Google Scholar
• Zheng Y, Hu FB, Ruiz-Canela M, et al. Metabolites of Glutamate Metabolism Are Associated With Incident Cardiovascular Events in the PREDIMED PREvencion con DIeta MEDiterranea (PREDIMED) Trial. J Am Heart Assoc. 2016;5(9):e003755. doi:10.1161/JAHA.116.00375527633391
   PubMed Web of Science ®Google Scholar
• Ottosson F, Smith E, Melander O, Fernandez C. Altered asparagine and glutamate homeostasis precede coronary artery disease and type 2 diabetes. J Clin Endocrinol Metab. 2018;103(8):3060–3069. doi:10.1210/jc.2018-0054629788285
   PubMed Web of Science ®Google Scholar
• Ruiz-Canela M, Toledo E, Clish CB, et al. Plasma branched-chain amino acids and incident cardiovascular disease in the PREDIMED Trial. Clin Chem. 2016;62(4):582–592. doi:10.1373/clinchem.2015.25171026888892
   PubMed Web of Science ®Google Scholar
• Magnusson M, Lewis GD, Ericson U, et al. A diabetes-predictive amino acid score and future cardiovascular disease. Eur Heart J. 2013;34(26):1982–1989. doi:10.1093/eurheartj/ehs42423242195
   PubMed Web of Science ®Google Scholar
• Yu E, Ruiz-Canela M, Guasch-Ferre M, et al. Increases in plasma tryptophan are inversely associated with incident cardiovascular disease in the Prevencion con Dieta Mediterranea (PREDIMED) Study. J Nutr. 2017;147(3):314–322.28179491
   PubMed Web of Science ®Google Scholar
• Meinitzer A, Seelhorst U, Wellnitz B, et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem. 2007;53(2):273–283. doi:10.1373/clinchem.2006.07671117185364
   PubMed Web of Science ®Google Scholar
• Ottosson F, Ericson U, Almgren P, et al. Dimethylguanidino valerate: a lifestyle-related metabolite associated with future coronary artery disease and cardiovascular mortality. J Am Heart Assoc. 2019;8(19):e012846. doi:10.1161/JAHA.119.01284631533499
   PubMed Web of Science ®Google Scholar
• O’Sullivan JF, Morningstar JE, Yang Q, et al. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J Clin Invest. 2017;127(12):4394–4402. doi:10.1172/JCI9599529083323
   PubMed Web of Science ®Google Scholar
• Shah SH, Sun JL, Stevens RD, et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J. 2012;163(5):844–850.e1. doi:10.1016/j.ahj.2012.02.00522607863
   PubMed Web of Science ®Google Scholar
• Obeid OA. Plasma amino acid concentrations in patients with coronary heart disease: a comparison between U.K. Indian Asian and Caucasian men. Int J Vitam Nutr Res. 2005;75(4):267–273. doi:10.1024/0300-9831.75.4.26716229343
   PubMed Web of Science ®Google Scholar
• Tobias DK, Lawler PR, Harada PH, et al. Circulating branched-chain amino acids and incident cardiovascular disease in a prospective cohort of US Women. Circ Genom Precis Med. 2018;11(4):e002157. doi:10.1161/CIRCGEN.118.00215729572205
   PubMed Web of Science ®Google Scholar
• Chen T, Ni Y, Ma X, et al. Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations. Sci Rep. 2016;6(1):20594. doi:10.1038/srep2059426846565
   PubMed Web of Science ®Google Scholar
• Yang RY, Wang SM, Sun L, et al. Association of branched-chain amino acids with coronary artery disease: a matched-pair case-control study. Nutr Metab Cardiovasc Dis. 2015;25(10):937–942. doi:10.1016/j.numecd.2015.06.00326231617
   PubMed Web of Science ®Google Scholar
• Zhang SY, Xuan C, Zhang XC, et al. Association Between MTHFR gene common variants, serum homocysteine, and risk of early-onset coronary artery disease: a case-control study. Biochem Genet. 2020;58(2):245–256. doi:10.1007/s10528-019-09937-x31552564
   PubMed Web of Science ®Google Scholar
• Xuan C, Liu ZF, Wang Q, et al. Increased serum concentrations of asymmetric dimethylarginine (ADMA) in patients with early-onset coronary artery disease. Clin Chim Acta. 2017;464:195–199. doi:10.1016/j.cca.2016.11.02827884754
   PubMed Web of Science ®Google Scholar
• Xuan C, Lun LM, Zhao JX, et al. L-citrulline for protection of endothelial function from ADMA-induced injury in porcine coronary artery. Sci Rep. 2015;5:10987.26046576
   PubMed Web of Science ®Google Scholar
• Xuan C, Chang FJ, Liu XC, et al. Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery. J Thorac Cardiovasc Surg. 2012;144(3):697–703. doi:10.1016/j.jtcvs.2012.01.02022336756
   PubMed Web of Science ®Google Scholar
• Xuan C, Tian QW, Li H, Zhang BB, He GW, Lun LM. Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: a meta-analysis based on 4713 participants. Eur J Prev Cardiol. 2016;23(5):502–510. doi:10.1177/204748731558609425956428
   PubMed Web of Science ®Google Scholar
• Xuan C, Bai XY, Gao G, Yang Q, He GW. Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8140 cases and 10,522 controls. Arch Med Res. 2011;42(8):677–685. doi:10.1016/j.arcmed.2011.11.00922154679
   PubMed Web of Science ®Google Scholar
• Xuan C, Li H, Li LL, et al. Screening and identification of pregnancy zone protein and leucine-rich Alpha-2-Glycoprotein as potential serum biomarkers for early-onset myocardial infarction using protein profile analysis. Proteomics Clin Appl. 2019;13(3):e1800079. doi:10.1002/prca.20180007930411527
   PubMed Web of Science ®Google Scholar
• Sarwar G, Botting HG, Collins M. A comparison of fasting serum amino acid profiles of young and elderly subjects. J Am Coll Nutr. 1991;10(6):668–674. doi:10.1080/07315724.1991.107181851770195
   PubMed Web of Science ®Google Scholar
• Kouchiwa T, Wada K, Uchiyama M, et al. Age-related changes in serum amino acids concentrations in healthy individuals. Clin Chem Lab Med. 2012;50(5):861–870. doi:10.1515/cclm-2011-084622628330
   PubMed Web of Science ®Google Scholar
• Fernstrom JD, Fernstrom MH. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr. 2007;137(6Suppl 1):1539S–1547S.17513421
   PubMed Web of Science ®Google Scholar
• Murr C, Grammer TB, Meinitzer A, Kleber ME, März W, Fuchs D. Immune activation and inflammation in patients with cardiovascular disease are associated with higher phenylalanine to tyrosine ratios: the Ludwigshafen risk and cardiovascular health study. J Amino Acids. 2014;2014:783730.24660059
   PubMedGoogle Scholar
• Xuan C, Tian QW, Zhang SY, et al. Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants. Ther Adv Chronic Dis. 2019;10:2040622319891539. doi:10.1177/204062231989153931839921
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni N. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys. 2006;43(5):275–283.17133733
   PubMed Web of Science ®Google Scholar
• Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(1):6. doi:10.1186/1475-2891-14-625577237
   PubMed Web of Science ®Google Scholar
• de Bree A, Verschuren WM, Blom HJ, Nadeau M, Trijbels FJ, Kromhout D. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis. 2003;166(2):369–377. doi:10.1016/S0021-9150(02)00373-812535751
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med. 2002;112(7):556–565. doi:10.1016/S0002-9343(02)01021-512015248
   PubMed Web of Science ®Google Scholar
• Bittl JA, Shine KI. Protection of ischemic rabbit myocardium by glutamic acid. Am J Physiol. 1983;245(3):H406–12. doi:10.1152/ajpheart.1983.245.3.H4066137148
   PubMed Web of Science ®Google Scholar
• Pisarenko OI, Solomatina ES, Ivanov VE, Studneva IM, Kapelko VI, Smirnov VN. On the mechanism of enhanced ATP formation in hypoxic myocardium caused by glutamic acid. Basic Res Cardiol. 1985;80(2):126–134. doi:10.1007/BF19104592860894
   PubMed Web of Science ®Google Scholar
• Qi L, Qi Q, Prudente S, et al. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA. 2013;310(8):821–828. doi:10.1001/jama.2013.27630523982368
   PubMed Web of Science ®Google Scholar
• Utagawa T. Production of arginine by fermentation. J Nutr. 2004;134(10 Suppl):2854S–2857S. doi:10.1093/jn/134.10.2854S15465800
   PubMed Web of Science ®Google Scholar
• Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85(3):342–350. doi:10.1136/heart.85.3.34211179281
   PubMed Web of Science ®Google Scholar
• Kalra K, Franzese CJ, Gesheff MG, et al. Pharmacology of antiplatelet agents. Curr Atheroscler Rep. 2013;15(12):371.24142550
   PubMed Web of Science ®Google Scholar
• Maralani MN, Movahedian A, ShH J. Antioxidant and cytoprotective effects of L-Serine on human endothelial cells. Res Pharm Sci. 2012;7(4):209–215.23248671
   PubMedGoogle Scholar
• Vallejo M, García A, Tuñón J, et al. Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal Bioanal Chem. 2009;394(6):1517–1524. doi:10.1007/s00216-009-2610-619172251
   PubMed Web of Science ®Google Scholar
• Shoulders MD, Raines RT. Collagen structure and stability. Annu Rev Biochem. 2009;78(1):929–958. doi:10.1146/annurev.biochem.77.032207.12083319344236
   PubMed Web of Science ®Google Scholar